New Issue: Barclays prices $10.01 million Accelerated Return Notes linked to Nasdaq Biotechnology

By Angela McDaniels

Tacoma, Wash., July 11 – Barclays Bank plc priced $10.01 million of 0% Accelerated Return Notes due Aug. 25, 2017 linked to the Nasdaq Biotechnology index, according to a 424B2 filing with the Securities and Exchange Commission.

The payout at maturity will be par of $10 plus triple any index gain, up to a maximum return of 19.2%. Investors will be exposed to any index decline.

BofA Merrill Lynch is the underwriter.

Issuer:	Barclays Bank plc
Issue:	Accelerated Return Notes
Underlying index:	Nasdaq Biotechnology
Amount:	$10,010,540
Maturity:	Aug. 25, 2017
Coupon:	0%
Price:	Par of $10
Payout at maturity:	Par plus 300% of any index gain, capped at 19.2%; exposure to any index decline
Initial level:	2,801.94
Final index level:	Average of index’s closing levels on five trading days ending Aug. 22, 2017
Pricing date:	July 7
Settlement date:	July 13
Underwriters:	BofA Merrill Lynch
Fees:	2%
Cusip:	06744K210

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.